Bank of America
ARLZ

Bank of America’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History

Bank of America’s Portfolio ARLZ Stock Details ARLZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-4,923
Closed -$2K – 7746
2018
Q2 		$2K Buy
4,923
+817
+20% +$670 ﹤0.01% 6946
2018
Q1 		$6K Sell
4,106
-914
-18% -$1.6K ﹤0.01% 6753
2017
Q4 		$7K Sell
5,020
-16,728
-77% -$27.5K ﹤0.01% 6696
2017
Q3 		$50K Buy
21,748
+5,507
+34% +$7.37K ﹤0.01% 5954
2017
Q2 		$22K Buy
16,241
+5,282
+48% +$7.63K ﹤0.01% 6205
2017
Q1 		$23K Buy
10,959
+4,142
+61% +$15.6K ﹤0.01% 6270
2016
Q4 		$30K Sell
6,817
-1,572
-19% -$7.46K ﹤0.01% 6173
2016
Q3 		$41K Sell
8,389
-13,594
-62% -$62K ﹤0.01% 5817
2016
Q2 		$73K Buy
21,983
+21,162
+2,578% +$79.9K ﹤0.01% 5684
2016
Q1 		$3K Buy
+821
New +$4.23K ﹤0.01% 6750

Other funds holding ARLZ

GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

Bank of America's ARLZ Position: Q3 2018 in Review

Bank of America sold out of Aralez Pharmaceuticals Inc. (ARLZ) in Q3 2018, closing a stake of 4,923 shares — an estimated $2K sold.

Bank of America first reported a position in ARLZ in Q1 2016 and held it in 10 quarters. The position peaked at $73K in Q2 2016. 4 funds tracked by Wall St. Rank hold ARLZ as of Q3 2018.

  • Bank of America reported no remaining Aralez Pharmaceuticals Inc. position as of Q3 2018 after selling out during the quarter.
  • Bank of America sold 4,923 Aralez Pharmaceuticals Inc. shares in Q3 2018, an estimated $2K.
  • Bank of America first reported a position in Aralez Pharmaceuticals Inc. in Q1 2016 and held it in 10 quarters.
  • Bank of America's Aralez Pharmaceuticals Inc. position peaked at $73K in Q2 2016.
  • 4 funds tracked by Wall St. Rank held Aralez Pharmaceuticals Inc. as of Q3 2018.

Based on Bank of America's 13F filing for Q3 2018, filed 14 Nov 2018.